Compare Invesco Solar ETF (TAN) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Solar ETF vs Zoetis Inc — how do they compare? Invesco Solar ETF trades at $52.39, while Zoetis Inc trades at $73.7 (market cap $31.14B). The key difference: Zoetis Inc pays a 2.81% dividend while Invesco Solar ETF pays none, and Invesco Solar ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.
| TAN | ZTS | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $73.95 | $156.76 |
52-Week Low | $36.62 | $71.91 |
Market Cap | — | $31.14B |
Enterprise Value | — | $38.70B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TAN trades at $52.41, up 1.06% in the last session, amid a bearish technical signal with selling pressure outweighing buys 11 to 4. Recent news highlights solar sector volatility and policy impacts, including new polysilicon tariffs under the Trump administration that may reshape U.S. solar manufacturing dynamics. The ETF's high beta of 1.41 indicates elevated sensitivity to market swings compared to broader energy funds.
Outlook is mixed: tariffs could boost U.S.-focused solar stocks but face headwinds from permit delays and weak residential demand. Risks include regulatory uncertainty and competition from nuclear energy. Analyst sentiment is cautious, with downgrades citing valuation and technical deterioration, though long-term growth drivers like AI energy demand persist.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Invesco Solar ETF
TAN is a thematic ETF that tracks the MAC Global Solar Energy Index. It provides targeted exposure to the global solar industry, including manufacturers of solar panels, installers, and component suppliers like Enphase and First Solar.
Read more on TAN →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
